BIRZ-227

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBIRZ-227
Drug Alias NameBIRZ-227
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor antagonists
TargetsLeukotriene B4 receptor
Therapy Area/IndicationsAlzheimer DiseaseAsthmaArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim Corp
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseAsthmaArthritis

Other Information

ATC CodeN/A
Related LinksN/A